Organization
Department of Pulmonology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands
2 abstracts
Abstract
SUNRAY-01, a pivotal, global study of olomorasib (LY3537982) in combination with pembrolizumab with or without chemotherapy for 1L treatment in KRAS G12C-mutant advanced NSCLC.Org: Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Medicine, Division of Hematology Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy, Department of Pulmonology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands, Institut du Thorax Curie Montsouris, Institut Curie, Paris, and UVSQ, Paris Saclay University, Versailles, France,
Abstract
Analysis of significant weight gain in patients using alectinib for ALK-positive lung cancer.Org: Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Erasmus MC University Medical Center, Erasmus Medical Center, Erasmus MC Kankerinstituut, Department of Pulmonary Medicine,